THE ROLE OF DNA TOPOISOMERASES II IN DRUG RESISTANCE
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 85 (2) , 241-245
- https://doi.org/10.1111/j.1365-2141.1993.tb03162.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 37 references indexed in Scilit:
- Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1992
- The role of DNA topoisomerases in recombination and genome stability: A double-edged sword?Cell, 1990
- Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIBiochemistry, 1989
- Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and IICell, 1988
- Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutantsCell, 1988
- DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombeCell, 1987
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- DNA topoisomerase II is required at the time of mitosis in yeastCell, 1985
- DNA TopoisomerasesAnnual Review of Biochemistry, 1985
- Epidermal growth factor-induced topoisomerase(s)Experimental Cell Research, 1983